Ashim Gupta Sells 47,671 Shares of UiPath Inc. (NYSE:PATH) Stock

UiPath Inc. (NYSE:PATH) CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

UiPath Trading Up 0.2 %

Shares of NYSE:PATH opened at $12.29 on Thursday. The stock’s 50-day moving average price is $12.12 and its two-hundred day moving average price is $16.03. UiPath Inc. has a 12-month low of $10.37 and a 12-month high of $27.87. The firm has a market cap of $7.04 billion, a price-to-earnings ratio of -76.81 and a beta of 0.87.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. The business had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The company’s revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.09) EPS. As a group, research analysts forecast that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on PATH. Needham & Company LLC restated a “hold” rating on shares of UiPath in a research report on Friday, September 6th. JPMorgan Chase & Co. dropped their price objective on UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. DA Davidson lifted their price objective on UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Wells Fargo & Company lifted their price objective on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th. Finally, Macquarie cut UiPath from an “outperform” rating to a “neutral” rating and dropped their price objective for the stock from $29.00 to $12.00 in a research report on Monday, June 3rd. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $17.71.

Hedge Funds Weigh In On UiPath

Hedge funds and other institutional investors have recently modified their holdings of the company. Mark Sheptoff Financial Planning LLC acquired a new position in shares of UiPath in the 4th quarter valued at about $25,000. ORG Partners LLC lifted its stake in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after purchasing an additional 1,112 shares in the last quarter. Lindbrook Capital LLC lifted its stake in shares of UiPath by 46.0% in the 1st quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock valued at $46,000 after purchasing an additional 639 shares in the last quarter. GAMMA Investing LLC lifted its position in UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock worth $50,000 after acquiring an additional 632 shares in the last quarter. Finally, Hantz Financial Services Inc. acquired a new position in UiPath during the 2nd quarter worth approximately $28,000. 62.50% of the stock is owned by institutional investors and hedge funds.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.